The latest closing stock price for TScan Therapeutics as of January 21, 2025 is 2.37.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-774 today, roughly -1 times their original investment - a -31.07% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 308.9% above the current share price.
The TScan Therapeutics 52-week low stock price is 2.31, which is 2.5% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 6.04.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-774 today, roughly -1 times their original investment - a -31.07% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 308.9% above the current share price.
The TScan Therapeutics 52-week low stock price is 2.31, which is 2.5% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 6.04.